Ian Shott

Eleanor has over 13 years’ experience in the pharmaceutical and contract research environment working with multinational companies such as Sanofi-Aventis and Covance. Eleanor holds a PhD in Chemistry/Pharmacology from The University of Sheffield. Her subsequent postdoctoral studies were carried out at the University of Liverpool under the supervision of Dr A. Stachulski and Professor P. M. O'Neill developing novel anti-parasitic and anti-malarial compounds.

In 2006, Eleanor moved to Sanofi–Aventis gaining significant expertise in the synthesis of both radiolabelled and stabled labelled compounds. As an APM accredited Project Manager Eleanor has a proven track record for successfully delivering projects and high quality materials to Clients globally.  In addition to this, Eleanor manages our diligent team of proposal specialists and CMC regulatory scientists.  

“Working with our Clients across our range of diverse and integrated services is a hugely rewarding experience, every day brings a new and exciting challenge”

Rachel holds a Masters degree in Chemistry from the University of York and started her career in the Netherlands as a Research Chemist for LANXESS Elastomers BV. She then transitioned into pharmaceutical contract research and specialised in the synthesis of both radiolabelled and stable labelled compounds at Covance.

Rachel also holds four years experience within scientific recruitment where she worked with global organisations across the pharmaceutical, healthcare, biotechnology and chemical sectors. She has extensive experience in account management, stakeholder engagement and high volume delivery, which she currently applies in her role as Client Proposal Coordinator at Arcinova.

After graduating in 2012, Faye has gained experience in Marketing and Events Management. Her previous roles have all been client centric, focussing on business development and sales.

Faye is a qualified project manager and holds an honours degree in Business with Marketing and an MSc in Project Management, both of which are from Northumbria University.

"We are very focussed on responding to customer enquiries, listening to their requirements and delivering on those in order to provide the best possible service. After all, the better we understand our clients requirements, the more efficient and effective we will be."

Originally a molecular biologist, Mark has spent 18 years in the drug discovery and development industry in both project management and commercial roles. Previous relevant positions include CEO at AIM-listed Physiomics plc, VP Business Development at Excelsyn and Director of Commercial Operations at BioFocus. 

Mark holds a degree in Genetics from the University of Nottingham, a PhD in Molecular Biology from the University of Newcastle and an MBA from Imperial College London.

"Throughout my career I have always been passionate about providing drug discovery and development services to customers. I gain a great deal of satisfaction from collaborating with biotechnology and pharmaceutical companies and being part of a team who deliver solutions that are often of critical importance to our partners."

Nathalie started her career as a synthetic and process chemist in drug discovery and development.

For the last 10 years, she has held various management positions in both tactical and strategic marketing and, more recently, in sales and business development, promoting services and products addressing the needs of the pharmaceutical and biotech markets in Europe, the Middle East and Africa.

Previous employers include Sigma-Aldrich, Excelsyn, AstraZeneca and Pharmorphix (now owned by Johnson Matthey).

Nathalie holds BSc and MSc degrees in Chemistry from the University of Strasbourg (France) and a PhD in Organic Chemistry from the University of York, and is fluent in French and German.

“I thrive in offering a consultative approach to sales and business development. Understanding our clients’ needs is key to ensure we offer the best solution to their specific requirements. I get the greatest satisfaction in the knowledge that we have successfully fulfilled those needs”

Masha brings over 20 years of Business Development and R&D experience to Arcinova, having previously served as business development executive for Catalent Pharma Solutions, DSM Pharmaceuticals and Cirrus Pharmaceuticals. 

As well as extensive R&D experience at Wyeth, Syngenta and Purdue University, Masha has played a key role in establishing a significant client base for two start-up companies. 

Masha holds a MS Degree in Molecular Biology from Moscow State Pedagogical University, and is fluent in Russian.

Masha is based in Raleigh, North Carolina and oversees business development activities for emerging pharma in the US.  

"Throughout my career I have always been passionate about science and building effective relationships by understanding the clients’ needs. The biggest reward is to see successful outcomes of collaborations that can help develop new medicines for patients. Being a part of an exceptionally talented team of life science professionals is very satisfying.”  

Since joining Arcinova in 2018, Louise has continuously contributed to Arcinova’s sales efforts, initially within the Client Service team and, more recently, in 2020, joining the Business Development team.  During this time, she has gained valuable skills and experience, which helped her progress into her current customer facing role. As a Business Development Associate, Europe, Louise fully supports the growth of our European sales, with a focus on UK clients.

Louise also has previous experience working as a laboratory analyst in a large pharmaceutical CMO, Piramal Healthcare,

“I enjoy the diversity of each client’s project; how each molecule requires a different customised solution to unlock its true potential. I find this extremely exciting”

Gail brings over 20 years of pharmaceutical sales and life sciences business development experience to Arcinova. She previously served as Senior Director of Business Development for Covance Early Clinical services, and PAREXEL Phase II-IV Clinical services. Most recently, Gail was Assistant Director, Strategic Business Development at the Duke Clinical Research Institute. Her career includes appointments at Merck, Pfizer, PPD and Charles River where she worked in various business development roles and managing key accounts.  

She holds a BS in Psychology from North Carolina State University and a BA in Criminal Justice Administration from the University of North Carolina at Chapel Hill.

Gail is based in Raleigh, North Carolina and oversees business development activities for Arcinova in the US.  

“I am honoured and privileged to work alongside world-renowned researchers and visionaries in the pharmaceutical industry. One of the most rewarding aspects of my job, is seeing the successful outcomes of their collaborations. Being a part of that team is extremely satisfying.”  

Alan is a PhD Organic Chemist with over 20 years experience in the synthesis of radiolabelled and stable labelled compounds. He has worked for a number of major organisations, including Sanofi, Covance and Wellcome. Alan completed his PhD at the University of Manchester and subsequently undertook Post Doctoral work at the University of Nottingham with Prof. G. Pattenden. He has extensive experience of working in a GLP/GMP regulated environment and acts as Site Radiation Protection Supervisor (RPS) with experience in dealing with regulatory bodies such as the Environment Agency (EA).

Lee is a biologist with 25 years experience of drug development in the pharmaceutical industry.  Key roles and responsibilities have included managing a team conducting drug metabolism, exploratory bioanalysis and in vitro biochemical assays. Lee is an experienced Study Director and lead scientist, responsible for the development of new technologies (eg LC-MS metabonomics platform). 

Lee is a graduate in Applied Biology from the University of Hertfordshire,

"The great days at work are when we find a way to overcome a client’s challenge and this new insight gives their data meaning and understanding.  That’s why it’s easy to become invested in a client project."

David is an analytical chemist and has worked in drug development in the pharmaceutical industry for over 30 years, both in big pharma and CRO environments. He has extensive experience in Quality Control, stability, method development and validation. 

David has an Honours degree in Applied Chemistry and his role includes providing advice to clients with respect to all aspect of pharmaceutical analysis and Quality Control of drug substance and drug products.  

“To assure the quality of drug substances and products, you need a team who have great knowledge of both analytical chemistry and the GMP regulations, and you can trust to deliver high quality data.”

John leads the Quality Assurance activities at ARCINOVA, spanning GCP, GLP and GMP; he has been a member of RQA for over 20 years.  John has over 30 years experience in the pharmaceutical industry with global pharmaceutical and contract research organisations, initially in lab-based roles before moving into Quality Assurance.

John is a Life Sciences graduate from Napier University in 1991, with a Certificate in Quality Management from Newcastle College (1995) and a Diploma in Research Quality Assurance from Anglia University (1997).

“Quality is at the heart of everything we do.”

After arriving at the Alnwick site as a formulation scientist, Simon now has over 30 years experience within pharmaceutical R&D formulation development, technical transfer and clinical manufacturing, spanning both “big pharma” and CRO environments. His responsibilities include providing advice to clients with respect to their manufacturing needs.

After graduating in pharmacy from the University of London, Simon completed a PhD in pharmaceutical microbiology from the University of Nottingham.

Simon is a registered pharmacist and is named on ARCINOVA's IMP Manufacturing Authorisation as the Head of Production, responsible for the manufacture and supply of IMPs to the clinic. 

“Working in a CRO environment provides the opportunity to work with many people on multiple, fast turnaround projects. The variety and achievement in delivering quality products provides a great intrinsic reward.”

Richard has seven years’ experience working in the pharmaceutical industry in both the contract research and contract manufacturing sectors, including over three years’ experience of leading teams in the development of small molecule syntheses to deliver gram to kilogram quantities of API and pharmaceutical intermediates.

He holds a PhD from the University of Nottingham for research undertaken in natural product synthesis and is a member of both the Royal Society of Chemistry and the Society of Chemical Industry.

Richard has a proven track record of new product introduction, from quotation through to product delivery and has led projects incorporating GMP manufacture and coordination of multifunctional project teams.

“Working with experts in their field to develop high quality, safe and efficient routes to complex APIs for drug development, clinical trials and ultimately commercial supply is a hugely rewarding experience.”

Mark is an organic chemist with over 10 years’ experience working in the pharmaceutical and fine chemical industries. He has particular expertise in Process Development and managing the scale-up of technically complex processes from grams to kilograms.

After graduating in Chemistry from the University of Manchester, Mark completed post-graduate studies in total synthesis at the University of Leeds He has extensive experience of working in a cGMP regulated environment and has a particular focus on controlling potential chemical reaction hazards and the management of Process Safety.

“Taking a lab procedure and developing it into one that can produce kilos of high value product safely, efficiently and with consistently high quality, is a challenge that is always enjoyable to address”

A chemistry research scientist by background, Giovanni is a committed CMC Regulatory Affairs Specialist and Project Manager, with large experience in the pharmaceutical industry, principally in the development of new chemical entities for use in pre-clinical and clinical studies.

After receiving his Diploma of Research in Biochemistry from the University of Bourgogne, France, he attained his Laurea (Master of Science Degree) in Organic Chemistry at the University of Bologna, Italy.

As a member of TOPRA, he has acquired a broad knowledge of regulatory affairs in the pharmaceutical industry, and specialises in writing CMC dossier sections for regulatory submissions.

He is an APM qualified Project Manager, with expertise in managing pharmaceutical projects for multinational clients, going from chemistry research and synthesis of drug substance, to development of drug products for early phase clinical trials.

Angela is a microbiologist and has worked in drug development in the pharmaceutical industry for over 30 years, both in big pharma and CRO environments.  She has experience in non-sterile and sterile products and her role includes providing advice to clients with respect to pharmaceutical microbiology and microbial quality assurance.

Angela graduated from the University of Strathclyde with an Honours degree in Applied Microbiology and over her career has been a member of various working groups within the industry including for bacterial endotoxins

Andy is a PRINCE2 practitioner qualified project manager with over 15 year experience of successfully leading and delivering projects in both the Large Molecule Biotechnology and Medical Device industries. Working with the industry’s leading multinational corporations he has a proven track record of using traditional project management tools and techniques to deliver on time and on budget innovative solutions to defined client deliverables.

He holds an Honours degree in Applied Biology from Northumbria University and has extensive experience managing projects within ISO and cGMP regulated environments within the U.K, EMEA, and Worldwide

Andy has a strong client focus and excellent communication skills, he excels at developing and building client relationships into trusted partners by ensuring on time and on budget project delivery through effective and open client communication, project visibility and control of all aspects of the project critical pathway accomplished utilising risk and stage gate management processes.

With a strong passion for continuous improvement using industry recognised Kaizen, Gemba and Root Cause Countermeasure techniques which he leverages to solve problems and drive process improvements throughout all levels of the organisation.

Zoë completed a Master’s degree in Chemistry from the University of Oxford before moving to University College London to study for a PhD in Chemistry and Peptide Synthesis. After completing a post-doctoral position at The Scripps Research Institute in La Jolla, CA she moved to Arcinova to work in the Isotope Labelling group making stable and radiolabelled drugs for use in clinical trials. She moved to work in the Project Management team in 2020.

“After working for nearly 3 years in the IL team, I am excited to transition to project management so I can be involved in the projects from start to finish, and to continue building relationships with clients as we help them succeed in their clinical trials and ultimately get a drug to market.”